6:07 PM
 | 
Oct 22, 2012
 |  BC Extra  |  Company News

FDA approves Eisai's epilepsy drug

FDA approved epilepsy drug Fycompa perampanel from Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) as adjunct...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >